We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$155M
Cap. Flow
+$46.4M
Cap. Flow %
2.13%
Top 10 Hldgs %
63.07%
Holding
32
New
4
Increased
13
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$118M
2
YUMC icon
Yum China
YUMC
+$104M
3
FDX icon
FedEx
FDX
+$90.6M
4
BABA icon
Alibaba
BABA
+$81.6M
5
GILD icon
Gilead Sciences
GILD
+$31.5M

Top Sells

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$80.1M
2
JD icon
JD.com
JD
+$76.9M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$74.4M
4
INTC icon
Intel
INTC
+$71.7M
5
CNX icon
CNX Resources
CNX
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 22.09%
2 Consumer Discretionary 21.41%
3 Industrials 17.02%
4 Healthcare 12.39%
5 Communication Services 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$173M 7.96%
1,294,385
-94,322
-7% -$12M
GE icon
2
GE Aerospace
GE
$368B
$155M 7.11%
2,960,026
+156,832
+6% +$7.72M
QCOM icon
3
Qualcomm
QCOM
$160B
$152M 6.96%
1,992,405
+91,605
+5% +$6.71M
CSCO icon
4
Cisco
CSCO
$448B
$150M 6.88%
2,739,861
-509,818
-16% -$28.2M
TPR icon
5
Tapestry
TPR
$30.8B
$140M 6.4%
4,397,123
+318,716
+8% +$9.94M
YUMC icon
6
Yum China
YUMC
$15.9B
$130M 5.96%
2,809,708
+2,386,169
+563% +$104M
GILD icon
7
Gilead Sciences
GILD
$163B
$127M 5.81%
1,874,005
+479,034
+34% +$31.5M
MRK icon
8
Merck
MRK
$321B
$123M 5.64%
+1,535,293
New +$118M
EXPE icon
9
Expedia Group
EXPE
$35.2B
$115M 5.29%
866,245
-6,819
-0.8% -$840K
B
10
Barrick Mining
B
$63.2B
$110M 5.06%
6,996,408
+245,860
+4% +$3.26M
KT icon
11
KT
KT
$8.8B
$109M 4.98%
8,772,746
-2,132,820
-20% -$26M
EFX icon
12
Equifax
EFX
$20.7B
$95.4M 4.38%
705,054
+175,789
+33% +$22M
FTI icon
13
TechnipFMC
FTI
$27.5B
$94.7M 4.35%
4,905,144
-756,784
-13% -$13.3M
COF icon
14
Capital One
COF
$129B
$87.2M 4%
960,580
+14,439
+2% +$1.29M
FDX icon
15
FedEx
FDX
$73B
$85M 3.9%
+517,424
New +$90.6M
BABA icon
16
Alibaba
BABA
$279B
$81.5M 3.74%
481,245
+473,010
+5,744% +$81.6M
META icon
17
Meta Platforms (Facebook)
META
$1.37T
$61.1M 2.81%
316,687
+29,740
+10% +$5.43M
BIDU icon
18
Baidu
BIDU
$36.5B
$50.7M 2.33%
432,284
-202,004
-32% -$28.8M
TIF
19
DELISTED
Tiffany & Co.
TIF
$38.3M 1.76%
409,354
+208,096
+103% +$20.7M
OC icon
20
Owens Corning
OC
$11.2B
$35.5M 1.63%
610,201
-220,326
-27% -$11.2M
CEF icon
21
Sprott Physical Gold and Silver Trust
CEF
$7.56B
$22.8M 1.05%
1,725,487
+85,692
+5% +$1.07M
MDT icon
22
Medtronic
MDT
$110B
$20.4M 0.94%
+209,920
New +$19.2M
IBN icon
23
ICICI Bank
IBN
$109B
$8.31M 0.38%
660,405
+85,827
+15% +$995K
KB icon
24
KB Financial Group
KB
$42.5B
$7.97M 0.37%
201,769
INTC icon
25
Intel
INTC
$460B
$6.42M 0.29%
134,203
-1,445,095
-92% -$71.7M

Similar funds

Antipodes Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Antipodes Partners held 32 positions worth $2.18B, up 7.7% from $2.02B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Antipodes Partners's Q2 2019 filing shows 4 new, 13 increased, 9 reduced and 5 closed positions. Its largest new stake was Merck: 1,535,293 shares worth $123M. The largest sale was Range Resources, an estimated $80.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Antipodes Partners's largest Q2 2019 buy was Merck: 1,535,293 shares worth $123M.
  • Antipodes Partners added most to Yum China in Q2 2019, an estimated $104M increase.
  • Antipodes Partners's biggest Q2 2019 reduction was JD.com, cutting an estimated $76.9M.
  • Antipodes Partners fully exited Range Resources in Q2 2019, selling an estimated $80.1M.
  • Antipodes Partners's ten largest holdings make up 63% of its $2.18B portfolio in Q2 2019.
  • Antipodes Partners opened 4 new positions and closed 5 in Q2 2019.
  • Antipodes Partners's portfolio value rose 7.7% quarter-over-quarter to $2.18B.

Based on Antipodes Partners's 13F filing for Q2 2019, filed 14 Aug 2019.